Fecal Calprotectin Testing Market Share

North American Market Forecast   

The North American fecal calprotectin testing market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the increasing frequency of colorectal cancer, celiac disease, and other disorders in developed countries, backed by the unhealthy lifestyle of the population. As per the data by the Center for Disease Control and Prevention (CDC), about 1 in 23 men and 1 in 25 women have the risk of colorectal cancer in the U.S. Further, the presence of a strong healthcare network in the region, along with the availability of specialized medical professionals for proper utilization of fecal calprotectin testing and the rapid surge in the focus of promoting fecal calprotectin testing to treat people with gastrointestinal diseases and others digestive health related concerns are also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry and rising commercialization of medical products are also anticipated to boost market growth during the forecast period.

APAC Market Statistics

On the other hand, the market in the Asia Pacific region is also estimated to witness noteworthy growth over the forecast period with a noteworthy CAGR on the back of improving healthcare systems, along with the high prevalence of gastrointestinal diseases in the region. In addition, the growing geriatric population and the rising disposable income of the people are other growth factors that are responsible for fueling a noteworthy revenue generation. Other than that, the presence of major key players in the region coupled with the rising awareness about fitness and health is also projected to increase the demand for fecal calprotectin testing for diagnosing underlying digestive system illnesses.